Filter
2799
Filtered Results: 2799
Text search:
SAHPRA
Featured
Recommendations
174
New Publications
551
Language
Document type
No document type
1501
Studies & Reports
789
Guidelines
215
Strategic & Response Plan
82
Manuals
81
Fact sheets
49
Training Material
31
Infographics
21
Situation Updates
11
Resource Platforms
10
Online Courses
4
Brochures
3
Dashboards/Maps
1
Videos
1
Countries / Regions
Global
165
Kenya
124
Africa
112
Ethiopia
102
South Africa
88
Malawi
78
Nigeria
74
Zambia
74
Tanzania
71
Uganda
64
Rwanda
49
Ghana
47
Senegal
46
Liberia
46
Sierra Leone
40
Zimbabwe
35
East and Southern Africa
35
India
35
Mozambique
33
West and Central Africa
31
Lesotho
30
Burkina Faso
30
Congo, Democratic Republic of
28
Benin
23
Cameroon
22
Namibia
20
Asia
17
South Sudan
17
Nepal
16
Middle East and North Africa
16
Latin America and the Carribbean
15
Guinea
14
Western and Central Europe
14
Bangladesh
14
Ukraine
13
Mali
13
Botswana
13
Syria
12
Germany
12
Eswatini/ Swaziland
11
Southern Africa
10
Central African Republic
10
Myanmar / Burma
10
South–East Asia Region
9
Haiti
7
Sudan
7
Yemen
7
Somalia
7
Philippines
6
Cambodia
6
Eastern Europe
6
Russia
6
Indonesia
6
China
5
Libya
5
Pakistan
5
Niger
4
Afghanistan
4
Côte d’Ivoire / Ivory Coast
4
Colombia
3
Thailand
3
Jordan
3
Sri Lanka
3
Angola
3
Chad
3
Madagascar
3
Tajikistan
2
Mexico
2
Togo
2
Congo-Brazzaville
2
Burundi
2
Italy
2
Jamaica
2
Mauritius
2
Egypt
2
Palestine
2
Gambia
1
Peru
1
Morocco
1
Armenia
1
USA
1
Dominican Republic
1
Guinea-Bissau
1
Venezuela
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
North America
1
Gabon
1
Tunisia
1
Lebanon
1
Papua New Guinea
1
Moldova
1
Honduras
1
Authors & Publishers
Publication Years
Category
Countries
1029
Clinical Guidelines
233
Public Health
178
Women & Child Health
136
Key Resources
96
Capacity Building
38
Pharmacy & Technologies
21
Annual Report MEDBOX
2
Toolboxes
HIV
473
Planetary Health
173
COVID-19
145
TB
138
Mental Health
121
NTDs
94
NCDs
86
Global Health Education
78
Health Financing Toolbox
77
Caregiver
70
Disability
61
Refugee
59
AMR
52
Rapid Response
43
Conflict
37
Ebola
31
Pharmacy
30
Natural Hazards
14
Polio
12
Social Ethics
11
Cholera
8
Specific Hazards
4
Zika
3
South Sudan
1
Health Financing
1
Typhoon
1
A year ago, the second Special Session of the World Health Assembly (WHASS) unanimously agreed to start a diplomatic process for a new binding instrument aimed at ensuring the international community is better prepared for the next health emergencies. The establishment of an Intergovernmental Negoti...
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si...
The Global Appeal provides updated information for government, private donors, partners and other readers interested in UNHCR's priorities and budgeted activities for 2021 to protect and improve the lives of tens of millions of people of concern (refugees, internally displaced people, stateless pers...
Hypertension is referred to as a “silent killer”. Most people with hypertension are unaware of their condition as in most cases, they experience no warning signs or symptoms hence they are not identified or treated. Hypertention is associated with a number of conditions, disability, and causes o...
In 2012, all Member States of the World Health Organization (WHO) endorsed a historical target to reduce premature mortality from noncommunicable diseases
(NCD). This commitment was echoed in 2015 by the United Nations Sustainable Development Goals, which included a target to reduce premature morta...
The World Heart Federation (WHF) Roadmap series covers a large range of cardiovascular conditions. These Roadmaps identify potential roadblocks and their solutions to improve the prevention, detection and management of cardiovascular diseases and provide a generic global framework available for loca...
The World Heart Federation (WHF) commenced a Roadmap initiative in 2015 to reduce the global burden of cardiovascular disease and resultant burgeoning of healthcare costs. Roadmaps provide a blueprint for implementation of priority solutions for the principal cardiovascular diseases leading to death...
Background
Cardiovascular diseases (CVDs) are one of the global leading causes of concern due to the rising prevalence and consequence of mortality and disability with a heavy economic burden. The objective of the current study was to analyze the trend in CVD incidence, mortality, and mortality-to-...
Many low- and middle-income countries (LMICs) are undergoing an epidemiological transition. With an improvement in socioeconomic conditions and an aging population, cardiovascular diseases (CVDs), like cardiac arrhythmias, are expected to increase in these countries. However, there are limited studi...
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm...
Background: COVID-19 is a global public health crisis that affects all sectors; studying the impact of this pandemic on the delivery of cardiology services in Africa is crucial as COVID-19-related cardiovascular complications may worsen the CVD burden in this already highly affected and resource-lim...
Introduction Community health workers (CHWs) are increasingly being tasked to prevent and manage cardiovascular disease (CVD) and its risk factors in underserved populations in low-income and middle-income countries (LMICs); however, little is known about the required training necessary for them to ...
Laboratory manual for yellow fever
recommended
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providing routine surveillance testing for yellow fever, wh...
Background
Noncommunicable diseases are major contributors to morbidity and mortality worldwide. Modifying the risk factors for these conditions, such as physical inactivity, is thus essential. Addressing the context or circumstances in which physical activity occurs may promote physical activity a...
The incidence and mortality of cardiovascular diseases (CVDs) in low and middle income countries (LMICs) have been increasing, while access to CVDs medicines is suboptimal. We assessed selection of essential medicines for the prevention and treatment of CVDs on national essential medicines lists (NE...
Background
Low- and middle-income countries now experience the highest prevalence and mortality rates of cardiovascular disease.
Main text
While improving the availability and delivery of proven, effective therapies will no doubt mitigate this burden, we posit that studies evaluating cardiovasc...
Approximately 80% of the 463 million adults worldwide with diabetes live in low-income and middle-income countries (LMICs). A major obstacle to designing evidence-based policies to improve diabetes outcomes in LMICs is the scarce availability of nationally representative data on the current patterns...
Around the world, more than 2 billion people lack access to safely managed water, sanitation and hygiene services, with conflicts and climate change exacerbating the issue.
Unsafe and insufficient WASH facilities, especially in rural and remote areas, can lead to increased health complications fo...
Diabetes is a serious, chronic disease that occurs either when the pancreas does not produce enough insulin (a hormone that regulates blood sugar, or glucose), or when the body cannot effectively use the insulin it produces. Diabetes is an important public health problem, one of four priority noncom...
